Skip to search formSkip to main contentSkip to account menu

Trilipix

National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Fenofibratefenofibric acid
Fenofibrate Delayed Release Oral Capsule [Trilipix]fenofibric acid 45 MG Delayed Release Oral Capsule [Trilipix]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
FDA changes label for Trilipix
FDA has changed the label for fenofibric acid (Trilipix, Abbott). It now carries a warning that the agent may not lower the risk… 
2011
2011
The US FDA has advised clinicians that fenofibric acid [Trilipix] may not lower the risk of heart attack
  • 2011
  • Corpus ID: 195167597
Highly Cited
2010
Highly Cited
2010
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
: Cardiovascular disease (CVD) represents the leading cause of mortality worldwide. Lifestyle modifications, along with low… 
2009
2009
Fenofibric Acid (trilipix).
2009
2009
NEW DRUGS Fenofibric Acid ( TriLipix ) Plus a Statin for Cholesterol
  • 2009
  • Corpus ID: 27506855
NEW DRUGS Fenofibric Acid (TriLipix) Plus a Statin for Cholesterol The FDA has approved Abbott’s feno fibric acid (TriLipix… 
2009
2009
Trilipix Approved for Lipid Management in Combo With a Statin
2009
2009
Trilipix Okayed As Cotherapy With a Statin
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)